Can GLP-1 medications treat type 1 diabetes?

GLP-1 medications are not FDA-approved for type 1 diabetes, but some endocrinologists prescribe them off-label for select patients. Potential benefits include reduced insulin requirements, improved glycemic control, and weight management. However, GLP-1 agonists don't replace insulin in type 1 diabetes - patients still require basal and bolus insulin. The risk of hypoglycemia increases significantly when combining GLP-1s with insulin. Research is ongoing, with some studies showing modest HbA1c improvements and insulin dose reductions. Type 1 diabetes patients considering GLP-1 medications should work closely with endocrinologists experienced in this off-label use and maintain intensive glucose monitoring.